Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma. | Front Genet | 2022 | 36186458 | PubTator, text mining | PubMed |
| Human placental mesenchymal stem cells regulate inflammation via the NF‑κB signaling pathway. | Exp Ther Med | 2022 | 36168408 | PubTator, text mining | PubMed |
| CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. | Hereditas | 2022 | 36167571 | PubTator, text mining | PubMed |
| Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors. | Front Genet | 2022 | 36159971 | PubTator, text mining | PubMed |
| Host immune response against DENV and ZIKV infections. | Front Cell Infect Microbiol | 2022 | 36159640 | PubTator, text mining | PubMed |
| Exome sequencing link mutation in RGPD4 with systemic sclerosis-associated interstitial lung disease and the low level of testosterone-an exploration study. | Front Oncol | 2022 | 36158696 | PubTator, text mining | PubMed |
| High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. | J Oncol | 2022 | 36157241 | PubTator, text mining | PubMed |
| IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas. | Transl Oncol | 2022 | 36156371 | PubTator, text mining | PubMed |
| Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases. | PLoS Genet | 2022 | 36155972 | PubTator, text mining | PubMed |
| The role of virus infections in Sjögren's syndrome. | Front Immunol | 2022 | 36148238 | PubTator, text mining | PubMed |
| A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization. | Front Pharmacol | 2022 | 36147340 | PubTator, text mining | PubMed |
| The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target. | Biomedicines | 2022 | 36140335 | PubTator, text mining | PubMed |
| Dectin-1 as a Potential Inflammatory Biomarker for Metabolic Inflammation in Adipose Tissue of Individuals with Obesity. | Cells | 2022 | 36139454 | PubTator, text mining | PubMed |
| Identification Markers of Carotid Vulnerable Plaques: An Update. | Biomolecules | 2022 | 36139031 | PubTator, text mining | PubMed |
| Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246. | Br J Cancer | 2022 | 36138076 | PubTator, text mining | PubMed |
| An Uncommon Correlation of Rheumatoid Arthritis and Lupus Nephritis: A Case Report on the Unusual Progression of Lupus Nephritis. | Cureus | 2022 | 36134049 | PubTator, text mining | PubMed |
| Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren's syndrome. | Front Mol Biosci | 2022 | 36133908 | PubTator, text mining | PubMed |
| IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation. | Front Immunol | 2022 | 36131914 | PubTator, text mining | PubMed |
| Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. | Clin Cancer Res | 2022 | 36129461 | PubTator, text mining | PubMed |
| Glucocorticoids mediate transcriptome-wide alternative polyadenylation: Potential mechanistic and clinical implications. | Clin Transl Sci | 2022 | 36128656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=41